Company intelligence / Profile preview

Immulok

Carpinteria, California, United States
Ownership
Private
Development stage
Other
01

Overview

Immulok was a U.S. diagnostics and laboratory products company active in the early 1980s that developed and commercialized immunology, microbiology, and immunofluorescence testing products. Its FDA-cleared product set included viral culture and typing reagents, immunofluorescent antibody assays, tissue immunoperoxidase kits, and radioimmunoassay products, indicating a focus on in vitro diagnostic testing rather than therapeutics. Historical records also show the company held patents on slide-incubation hardware used in immunoassays. The company appears to be inactive today and historical corporate records indicate it was merged out, with later records linking it to Johnson & Johnson-era Raritan, New Jersey addresses. For biotech analysts, Immulok is best understood as a defunct historical diagnostics/medtech company rather than a current drug-development biotech.

Therapeutic areas
ImmunologyOtherInfectious Diseases
Modalities
DeviceBiologic
Industry
Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Immulok.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immulok.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call